Docon Technologies Private Limited - Due diligence report

A 360° intelligence report on Docon Technologies: trust score, financial health, credit view, compliance, directors, growth and distress sig…

2016-06-20 Thane, Maharashtra Active Unlisted Active Compliant
Share
DT Docon Technologies Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Docon Technologies — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Docon Technologies is assessed as Low Risk with a Trust Score of 82/100. Docon Technologies is an active private limited indian non-government company incorporated in 2016, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Docon Technologies Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • Moderate gearing (D/E 38%).

Charges position: 1 open (1,700.00 cr) · 11 satisfied (6,407.76 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others12 48.0 cr
Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 6 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
PRANAV SAXENA 01234567 Director 01/04/2018 6 yrs Approved
DHAVAL RAJESH SHAH 01234567 Director 01/04/2018 6 yrs Approved
HARDIK KISHOR DEDHIA 01234567 Director 01/04/2018 6 yrs Approved
Shrestha Kapoor 01234567 Director 01/04/2018 6 yrs Approved
Pankaj Kumar Jain 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Api Holdings Limited
Subsidiaries
2
Group entities
3
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Nueclear Healthcare Limited Subsidiary Company 74.00%
Api Holdings Limited Holding Company 74.00%
Thyrocare Technologies Limited Subsidiary Company 74.00%
Pulse Hitech Health Services (ghatkopar) Llp Subsidiary Company 74.00%
Equinox Labs Limited Associate Company 74.00%

Key managerial personnel: PRANAV SAXENA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Asset base grew 24% - capacity expansion.
Operating for 10+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment64/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 1,700.00 cr already registered.
  • Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
26 Nov 2025
Director appointed
Pankaj Kumar Jain (Cfo)
14 Oct 2025
Director ceased
SHRESTHA KAPOOR
30 Sep 2025
Last AGM held
Annual general meeting
15 Sep 2025
Charge satisfied
Others
11 Sep 2025
Charge created
Others - 1,700.00 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
01 Oct 2024
Director appointed
PRANAV SAXENA (Managing Director)
Director ceased
PRANAV SAXENA
12 Aug 2024
Director appointed
Shrestha Kapoor (Cfo)
13 Nov 2023
Director ceased
DHAVAL RAJESH SHAH
31 Jan 2023
Director appointed
DHAVAL RAJESH SHAH (Director)
08 Jul 2022
Charge satisfied
Others
07 Jul 2022
Charge satisfied
Others
06 Jul 2022
Charge satisfied
Others
01 Jul 2022
Charge satisfied
Others
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
6 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Innovinc Healthcare Private Limited U85100MH2019PTC328821 Nagpur, Maharashtra, India
Gian Life Care Limited L85100UP2018PLC110119 Kanpur, Uttar Pradesh, India
Mohan Pritilata Medical & Research Centre Private Limited U85100WB2013PTC194945 South Twenty Four Parganas, West Bengal, India
Lub Dub Medical Technologies Private Limited U33112TN2000PTC045183 Chennai, Tamil Nadu, India
Clinico Diagnostic Centre India Private Limited U93030MH2011PTC216647 Mumbai, Maharashtra, India
Genepath Dx U74999PN2019PTC181759 Pune, Maharashtra, India
Dr. Khannas Pathcare Private Limited U51100DL2004PTC126416 New Delhi, Delhi, India
Dr Lal Pathlabs U74220MP2019PTC049171 Indore, Madhya Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Docon Technologies before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Docon Technologies: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Docon Technologies - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Docon Technologies pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Docon Technologies - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Docon Technologies an active company?

Docon Technologies has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Docon Technologies financially healthy?

Docon Technologies has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Docon Technologies?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Docon Technologies?

The ultimate holding entity is Api Holdings Limited. 5 active director(s) are on record.

Does Docon Technologies have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 11 earlier charge(s) stand satisfied.

Is Docon Technologies up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Docon Technologies?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.